Ligand validation:7I2N

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7I2N_MES_A_1003	23%	74%	0.28	0.902	0.72	0.29	-	-	0	0	100%	18
7I2X_MES_A_1004	98%	52%	0.063	0.983	0.88	0.96	-	1	0	0	100%	0.25
5K5M_MES_A_1004	55%	8%	0.211	0.981	3.74	1.05	4	1	1	0	100%	0.5
7HL8_MES_A_1003	48%	71%	0.208	0.954	0.75	0.39	-	-	0	0	100%	0.25
7HKQ_MES_A_1003	43%	72%	0.223	0.95	0.71	0.37	-	-	0	0	100%	0.25
7HKU_MES_A_1003	43%	68%	0.228	0.952	0.78	0.47	-	-	0	0	100%	0.25
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
9K7M_MES_A_401	100%	67%	0.022	0.998	0.69	0.57	-	-	0	0	100%	1
5TNY_MES_A_501	100%	10%	0.03	0.994	1.72	2.64	1	6	0	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.